Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000795317 | SCV000934772 | likely pathogenic | Dystonic disorder | 2018-11-21 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been observed to be de novo in an individual affected with dystonia (PMID: 27666935). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 510 of the ANO3 protein (p.Glu510Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. |
Institute of Human Genetics Munich, |
RCV000995494 | SCV001149683 | pathogenic | Dystonia 24 | 2019-06-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004719992 | SCV005326221 | likely pathogenic | not provided | 2023-11-20 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30455893, 33388357, 31053532, Boddu2023[preprint], 33098801, 35872528, 30502610, 33247415, 27666935, 33488508) |